Tumor-targeting and efficacy of B7H3/GD2 bispecific SNIPER antibodies

被引:0
|
作者
Erbe, Amy K. [1 ]
Feils, Arika [1 ]
Rosenkrans, Zack [1 ]
Wiwczar, Jessica [2 ]
Gerhardt, Daniel [2 ]
Hammer, Bonnie [2 ]
Felder, Mildred [1 ]
Bercher, Mark [2 ]
Hampton, Alina [1 ]
Frankel, Lizzie [1 ]
Spiegelman, Dan [1 ]
Tsarovsky, Noah [1 ]
Rakhmilevich, Alexander [1 ]
Hank, Jacquelyn [1 ]
Glaser, Bryan [2 ]
Hernandez, Reinier [1 ]
Green, Roland [2 ]
Sondel, Paul M. [1 ]
机构
[1] Univ Wisconsin, Madison, WI 53706 USA
[2] Invenra Inc, Madison, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2019
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [1] GD2/B7-H3 bispecific antibodies for next-generation neuroblastoma treatment
    Hernandez, Reinier
    Erbe, Amy
    Gerhardt, Daniel
    Dennin, Jennifer
    Massey, Christopher
    Barnhart, Todd
    Engle, Jonathan
    Hammer, Bonnie
    Sondel, Paul
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [2] GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
    Jeong A. Park
    Nai-Kong V. Cheung
    Journal of Hematology & Oncology, 13
  • [3] GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
    Park, Jeong A.
    Cheung, Nai-Kong V.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [4] Incorporating Radioimmunotherapy Targeting B7H3 in Pediatric Tumors
    Kramer, Kim
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [5] Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy
    Cheng, Ming
    Ahmed, Mahiuddin
    Xu, Hong
    Cheung, Nai-Kong V.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (02) : 476 - 486
  • [6] Intraventricular radioimmunotherapy targeting B7H3 for CNS malignancies.
    Kramer, Kim
    Pandit-Taskar, Neeta
    Donzelli, Maria
    Wolden, Suzanne L.
    Zanzonico, Pat
    Humm, John
    Haque, Sofia
    Souweidane, Mark M.
    Lewis, Jason
    Lvashchenko, Serge K.
    Larson, Steven M.
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] The bispecific antibody KA-3008, targeting both EGFR and B7H3, increases internalization and minimizes on-target, off-tumor toxicity
    Wu, Guojin
    Ding, Li
    Peng, Hao
    Hao, Feng
    He, Feng
    Ning, Jinying
    CANCER RESEARCH, 2023, 84 (06)
  • [8] Potent Anti-Tumor Effect Using T Cells Armed with Recombinant Anti-GD2 Bispecific Antibodies Against GD2 Positive Tumor
    Nakajima, M.
    Guo, H.
    Hoseini, S. S.
    Xu, H.
    Cheung, N. K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S54 - S54
  • [9] Development of DNA aptamers targeting B7H3 by hybrid-SELEX: an alternative to antibodies for immuno-assays
    Maradani, Bhavani Shankar
    Parameswaran, Sowmya
    Subramanian, Krishnakumar
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Development of GD2 and CD3 Targeted Bispecific T-Cell Engaging Antibodies for Neuroblastoma
    Patel, A.
    Thevanesan, C.
    Anderson, J.
    Pule, M.
    Straathof, K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S136 - S137